[{"address1": "82 Richmond Street East", "city": "Toronto", "state": "ON", "zip": "M5C 1P1", "country": "Canada", "phone": "888-846-3171", "website": "https://www.pharmather.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia and procedural sedation. It develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures. In addition, the company offers PHARMAPATCH, a microneedle patch technology solution, which includes hydrogel-forming and gelatin methacryloyl delivery system for the treatment of psychedelics and infectious diseases. Further, it has license agreement with BioRAE, Inc. for the development and commercialization of a novel biocompatible and biodegradable gelatin methacryloyl microneedle; and the University of Kansas to develop and commercialize the intellectual property of ketamine to treat ALS; as well as holds a patent and know-how license agreement with The Queen's University of Belfast to develop and commercialize hydrogel-forming microneedle patch delivery technology. The company was incorporated in 2019 and is headquartered in Toronto, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Fabio  Chianelli", "age": 46, "title": "Founder, Chairman & CEO", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 251604, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Carmelo  Marrelli ACIS, B.Comm., C.A., C.P.A., CGA, CPA", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 56031, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Todd", "age": 66, "title": "Corporate Secretary", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "maxAge": 86400, "priceHint": 4, "previousClose": 0.146, "open": 0.1377, "dayLow": 0.1377, "dayHigh": 0.145, "regularMarketPreviousClose": 0.146, "regularMarketOpen": 0.1377, "regularMarketDayLow": 0.1377, "regularMarketDayHigh": 0.145, "volume": 20600, "regularMarketVolume": 20600, "averageVolume": 251676, "averageVolume10days": 133340, "averageDailyVolume10Day": 133340, "bid": 0.145, "ask": 0.15, "marketCap": 12835270, "fiftyTwoWeekLow": 0.123, "fiftyTwoWeekHigh": 0.32, "fiftyDayAverage": 0.15928, "twoHundredDayAverage": 0.16743, "currency": "USD", "sharesOutstanding": 88519104, "heldPercentInsiders": 0.18679, "heldPercentInstitutions": 0.00056, "impliedSharesOutstanding": 89423400, "bookValue": 0.026, "priceToBook": 5.576923, "lastFiscalYearEnd": 1717113600, "nextFiscalYearEnd": 1748649600, "mostRecentQuarter": 1732924800, "trailingEps": -0.03, "52WeekChange": 0.08955228, "SandP52WeekChange": 0.21142256, "exchange": "OQB", "quoteType": "EQUITY", "symbol": "PHRRF", "underlyingSymbol": "PHRRF", "shortName": "PharmaTher Holdings Ltd.", "longName": "PharmaTher Holdings Ltd.", "firstTradeDateEpochUtc": 1610116200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "c803110a-9e43-31dc-b880-bad4432bf588", "messageBoardId": "finmb_671235862", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.145, "recommendationKey": "none", "financialCurrency": "CAD", "trailingPegRatio": null, "__fetch_time": "2025-02-08"}]